Zobrazeno 1 - 10
of 111
pro vyhledávání: '"GA Denomme"'
Publikováno v:
Blood. 83:3232-3239
Heparin-induced thrombocytopenia (HIT) is an important complication of heparin therapy. Although there is general agreement that platelet activation in vitro by the HIT IgG is mediated by the platelet Fc receptor, the interaction among the antibody,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f443b27d1c2debf2d9e0ecd1108d46db
https://doi.org/10.1182/blood.v83.11.3232.bloodjournal83113232
https://doi.org/10.1182/blood.v83.11.3232.bloodjournal83113232
Publikováno v:
Europe PubMed Central
Heparin-induced thrombocytopenia (HIT) is an important complication of heparin therapy. Although there is general agreement that platelet activation in vitro by the HIT IgG is mediated by the platelet Fc receptor, the interaction among the antibody,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::16017af6fe85db449b3a4a4c06776ce3
http://europepmc.org/abstract/med/8193358
http://europepmc.org/abstract/med/8193358
Autor:
Rego S; BillionToOne, Inc, Menlo Park, and the Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California; Obstetrix Maternal-Fetal Medicine Specialists, Houston, Grifols Laboratory Solutions Inc, San Marcos, and the Department of Women's Health, Dell Medical School, University of Texas at Austin, and the Comprehensive Fetal Care Center, Dell Children's Medical Center, Austin, Texas; and the Division of Maternal-Fetal Medicine, Department of Women's and Infant's Services, MedStar Washington Hospital Center, Washington, DC., Ashimi Balogun O, Emanuel K, Overcash R, Gonzalez JM, Denomme GA, Hoskovec J, King H, Wilson A, Wynn J, Moise KJ Jr
Publikováno v:
Obstetrics and gynecology [Obstet Gynecol] 2024 Oct 01; Vol. 144 (4), pp. 436-443. Date of Electronic Publication: 2024 Jul 25.
Autor:
Drews SJ; Microbiology, Canadian Blood Services, Edmonton, Alberta, Canada.; Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada., Charlton C; Microbiology, Canadian Blood Services, Edmonton, Alberta, Canada.; Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada., O'Brien SF; Epidemiology and Surveillance, Canadian Blood Services, Ottawa, Ontario, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada., Burugu S; Grifols Canada Ltd, Mississauga, Ontario, Canada., Denomme GA; Grifols Laboratory Solutions, San Marcos, Texas, USA.
Publikováno v:
Vox sanguinis [Vox Sang] 2024 Jun; Vol. 119 (6), pp. 624-629. Date of Electronic Publication: 2024 Mar 14.
Autor:
Sippert E; Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland. Electronic address: emilia.sippert@fda.hhs.gov., Volkova E; Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Rippee-Brooks M; Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Denomme GA; Versiti Blood Research Institute, Versiti Blood Center of Wisconsin, Milwaukee, Wisconsin; Diagnostic Laboratories, Versiti Blood Center of Wisconsin, Milwaukee, Wisconsin., Flegel WA; Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland., Lee C; Office of Minority Health and Health Equity, Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland., Araojo R; Office of Minority Health and Health Equity, Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland., Illoh O; Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Liu Z; Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland., Rios M; Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland. Electronic address: maria.rios@fda.hhs.gov.
Publikováno v:
The Journal of molecular diagnostics : JMD [J Mol Diagn] 2024 Jun; Vol. 26 (6), pp. 456-466. Date of Electronic Publication: 2024 Mar 16.
Autor:
Denomme GA; Medical Affairs, Grifols Diagnostic Solutions, San Marcos, and Department of Health Sciences, School of Health Professions, UT Health, San Antonio, TX, United States of America.
Publikováno v:
Blood transfusion = Trasfusione del sangue [Blood Transfus] 2024 May; Vol. 22 (3), pp. 185-186.
Autor:
Gassner C; Institute of Translational Medicine, Private University in the Principality of Liechtenstein, Triesen, Liechtenstein., Castilho L; University of Campinas/Hemocentro, Campinas, Brazil., Chen Q; Jiangsu Province Blood Center, Nanjing, Jiangsu, China., Clausen FB; Department of Clinical Immunology, Laboratory of Blood Genetics, Copenhagen University Hospital, Copenhagen, Denmark., Denomme GA; Grifols Laboratory Solutions, San Marcos, Texas, USA., Flegel WA; Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Gleadall N; Department of Haematology, University of Cambridge and NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK., Hellberg Å; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden., Ji Y; Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou, People's Republic of China., Keller MA; American Red Cross Blood Services, Philadelphia, Pennsylvania, USA., Lane WJ; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Ligthart P; Department of Diagnostic Immunohematology, Sanquin, Amsterdam, The Netherlands., Lomas-Francis C; Laboratory of Immunohematology and Genomics, New York Blood Center Enterprise, New York, New York, USA., Nogues N; Banc de Sang i Teixits, Barcelona, Spain., Olsson ML; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden.; Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden., Peyrard T; Etablissement Français du Sang Ile-de-France, Centre National de Référence pour les Groupes sanguins, Ivry-sur-Seine, France.; UMR_S1134 Inserm Université Paris Cité, Paris, France., Storry JR; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden.; Department of Laboratory Medicine, Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden., Tani Y; Osaka Red Cross Blood Center, Osaka, Japan., Thornton N; International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK., van der Schoot E; Department of Experimental Immunohematology, Sanquin, Amsterdam, The Netherlands., Veldhuisen B; Department of Diagnostic Immunohematology, Sanquin, Amsterdam, The Netherlands.; Department of Experimental Immunohematology, Sanquin, Amsterdam, The Netherlands., Wagner F; German Red Cross Blood Service NSTOB, Springe, Germany.; MVZ Clementinenkrankenhaus, Springe, Germany., Weinstock C; Department of Transfusion Medicine, Institute for Clinical Transfusion Medicine and Immunogenetics, German Red Cross Blood Service, Ulm, Germany., Wendel S; Blood Bank, Hospital Sirio-Libanes, São Paulo, Brazil., Westhoff C; Laboratory of Immunohematology and Genomics, New York Blood Center Enterprise, New York, New York, USA., Yahalom V; Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Hyland CA; Australian Red Cross Lifeblood, Brisbane, Australia.
Publikováno v:
Vox sanguinis [Vox Sang] 2022 Nov; Vol. 117 (11), pp. 1332-1344. Date of Electronic Publication: 2022 Sep 19.
Autor:
Achram R; Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA., Denomme GA; Grifols Laboratory Solutions Inc., San Marcos, Texas, USA., Stef MA; Grifols Laboratory Solutions Inc., San Marcos, Texas, USA., Nguyen TTA; Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA., Delvadia B; Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA., Thompson L; Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA., Josephson CD; Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA., Roback JD; Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA., Sullivan HC; Department of Pathology and Laboratory Medicine, Center for Transfusion and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, USA.
Publikováno v:
Transfusion [Transfusion] 2022 Jul; Vol. 62 (7), pp. 1452-1456. Date of Electronic Publication: 2022 Jun 24.
Autor:
Al-Riyami AZ; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman., Al Hinai D; College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman., Al-Rawahi M; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman., Al-Hosni S; Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman., Al-Zadjali S; Sultan Qaboos Comprehensive Cancer Centre, Muscat, Oman., Al-Marhoobi A; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman., Al-Khabori M; Department of Haematology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman., Al-Riyami H; Department of Genetics, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman., Denomme GA; Diagnostic Laboratories, Versiti Blood Center of Wisconsin, Milwaukee, Wisconsin, USA.
Publikováno v:
Vox sanguinis [Vox Sang] 2022 Mar; Vol. 117 (3), pp. 424-430. Date of Electronic Publication: 2021 Oct 13.
Autor:
Clausen FB; Laboratory of Blood Genetics, Department of Clinical Immunology, Copenhagen University Hospital, Copenhagen, Denmark.; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands., Hellberg Å; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden., Bein G; Institute for Clinical Immunology and Transfusion Medicine, Justus-Liebig-University, Giessen, Germany., Bugert P; Institute of Transfusion Medicine and Immunology, Heidelberg University, Medical Faculty Mannheim, German Red Cross Blood Service Baden Württemberg - Hessen, Mannheim, Germany., Schwartz D; Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria., Drnovsek TD; Blood Transfusion Centre of Slovenia, Ljubljana, Slovenia., Finning K; National Health Service Blood and Transplant, International Blood Group Reference Laboratory, UK., Guz K; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Haimila K; Finnish Red Cross Blood Service, Helsinki, Finland., Henny C; Interregional Blood Transfusion SRC, Berne, Switzerland., O'Brien H; Clinical Services and Research, Australian Red Cross Lifeblood, Brisbane, Australia., Orzinska A; Institute of Hematology and Transfusion Medicine, Warsaw, Poland., Sørensen K; Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway., Thorlacius S; The Blood Bank, Landspitali University Hospital, Reykjavik, Iceland., Wikman A; Clinical Immunology and Transfusion Medicine Karolinska University Hospital and CLINTEC Karolinska Institutet, Stockholm, Sweden., Denomme GA; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Versiti Blood Research Institute and Diagnostic Laboratories, Milwaukee, Wisconsin, USA., Flegel WA; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Department of Transfusion Medicine, NIH Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Gassner C; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Institute for Translational Medicine, Private University in the Principality of Liechtenstein, Triesen, Liechtenstein., de Haas M; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Department of Immunohaematology Diagnostic Services, Sanquin Diagnostic Services and Sanquin Research, Amsterdam, The Netherlands.; Department of Haematology, Leiden University Medical Center, Leiden, The Netherlands., Hyland C; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Clinical Services and Research, Australian Red Cross Lifeblood, Brisbane, Australia.; School of Biomedical Sciences, Queensland University of Technology, Brisbane, Queensland, Australia., Ji Y; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Guangzhou Blood Center, Institute of Clinical Blood Transfusion, Guangzhou, China., Lane WJ; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Nogués N; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Immunohematology Laboratory, Blood and Tissue Bank, Barcelona, Spain., Olsson ML; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Department of Clinical Immunology and Transfusion Medicine, Office for Medical Services, Region Skåne, Sweden.; Department of Laboratory Medicine, Lund University, Lund, Sweden., Peyrard T; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Institut National de la Transfusion Sanguine, Centre National de Référence pour les Groupes Sanguins, Paris, France., van der Schoot CE; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Department of Experimental Immunohematology, Sanquin Research, Amsterdam, The Netherlands., Weinstock C; cfDNA subgroup from the International Society of Blood Transfusion (ISBT) Working Party on Red Cell Immunogenetics and Blood Group Terminology (RCIBGT), Amsterdam, The Netherlands.; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Service Baden-Württemberg-Hessen, and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany., Legler T; Department of Transfusion Medicine, University Medical Center Göttingen, Göttingen, Germany.
Publikováno v:
Vox sanguinis [Vox Sang] 2022 Feb; Vol. 117 (2), pp. 157-165. Date of Electronic Publication: 2021 Jun 21.